Incorporated in 1985, Shri Jagdamba Polymers Ltd manufactures technical textile, geo textile and other allied products
The company benefits from a cost and scale advantage within the technical textiles niche, specifically in HDPE/PP woven fabrics. While high ROCE and ROE suggest a competitive edge, the lack of strong brand power or high switching costs limits this to a narrow moat primarily driven by operational efficiency and export focus.
Management has consistently reinvested earnings into capacity expansion and renewable energy projects, such as the 8MW solar plant, to lower operational costs. They maintain a conservative balance sheet with very low debt while providing modest, consistent dividends to shareholders.
The investment collapsed as the company's operational efficiency was neutralized by rising energy costs and a global shift away from polypropylene-based technical textiles. The administrative sloppiness observed in FY24—marked by repeated regulatory filing failures and the sudden resignation of the statutory auditor—foreshadowed a deeper breakdown in internal controls. As margins compressed in a commoditized export market, the lack of a brand moat left the company unable to pass on costs, while related-party dealings with promoter-controlled entities like Shakti Polyweave eventually drained minority shareholder value during the downturn.
RichFakir rates Shri Jagdamba Polymers Ltd's business quality as decent — 66/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Shri Jagdamba Polymers Ltd is trading about 31% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shri Jagdamba Polymers Ltd is: Buy candidate. A decent business trading below what we think it is worth — so it makes our buy list.
RichFakir's educational estimate of Shri Jagdamba Polymers Ltd's fair value is about ₹1,116 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →